These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33355506)

  • 1. Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells.
    Brand RM; Moore BA; Zyhowski A; Siegel A; Uttam S; Metter EJ; Engstrom J; Brand RE; Biswas N; Whitcomb DC; Binion DG; Schwartz M; McGowan I
    Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G396-G410. PubMed ID: 33355506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system promotes colonic inflammation by inducing T
    He L; Du J; Chen Y; Liu C; Zhou M; Adhikari S; Rubin DT; Pekow J; Li YC
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G774-G784. PubMed ID: 30995068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib.
    van Gennep S; Fung ICN; Jong DC; Ramkisoen RK; Clasquin E; de Jong J; de Vries LCS; de Jonge WJ; Gecse KB; Löwenberg M; Woolcott JC; Mookhoek A; D'Haens GR
    J Crohns Colitis; 2024 Aug; 18(8):1283-1291. PubMed ID: 38506097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired IFN-γ-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
    Cordes F; Lenker E; Weinhage T; Spille LJ; Bettenworth D; Varga G; Schmidt HH; Foell D
    Inflamm Bowel Dis; 2021 May; 27(6):887-901. PubMed ID: 33165509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib for the treatment of ulcerative colitis.
    Izzo R; Bevivino G; Monteleone G
    Expert Opin Investig Drugs; 2016 Aug; 25(8):991-7. PubMed ID: 27177233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Cordes F; Lenker E; Spille LJ; Weinhage T; Bettenworth D; Kessel C; Schmidt HH; Foell D; Varga G
    Inflamm Bowel Dis; 2020 Feb; 26(3):391-406. PubMed ID: 31560043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological responsiveness of intestinal tissue explants and mucosal mononuclear cells to ex vivo stimulation.
    Brand RM; Biswas N; Siegel A; Myerski A; Engstrom J; Jeffrey Metter E; Brand RE; Cranston RD; McGowan I
    J Immunol Methods; 2018 Dec; 463():39-46. PubMed ID: 30218652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway.
    Yun Y; Chen J; Wang X; Li Y; Hu Z; Yang P; Qin L
    Biomed Res Int; 2021; 2021():8877056. PubMed ID: 33511217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis.
    Lechner K; Mott S; Al-Saifi R; Knipfer L; Wirtz S; Atreya R; Vieth M; Rath T; Fraass T; Winter Z; August A; Luban J; Zimmermann VS; Weigmann B; Neurath MF
    Gastroenterology; 2021 Oct; 161(4):1270-1287.e19. PubMed ID: 34224738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1.
    Hartwig O; Loretz B; Nougarede A; Jary D; Sulpice E; Gidrol X; Navarro F; Lehr CM
    J Control Release; 2022 May; 345():646-660. PubMed ID: 35339579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Macromolecular Janus Kinase (JAK) Inhibitor Prodrug Effectively Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.
    Zhao G; Wei X; Wu J; Eichele DD; Lele SM; Yang L; Zhang F; Wang D
    Pharm Res; 2019 Mar; 36(4):64. PubMed ID: 30859327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect and mechanism of tofacitinib on the secretion of cytokines by T cells in human peripheral blood].
    Wu K; Zhao J; Wu Q; Wu C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1448-1455. PubMed ID: 29268845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients.
    Lethen I; Lechner-Grimm K; Gabel M; Knauss A; Atreya R; Neurath MF; Weigmann B
    Inflamm Bowel Dis; 2024 Jul; 30(7):1151-1163. PubMed ID: 38142236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.
    Cordes F; Foell D; Ding JN; Varga G; Bettenworth D
    World J Gastroenterol; 2020 Jul; 26(28):4055-4075. PubMed ID: 32821070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tofacitinib in ulcerative colitis.
    Archer TP; Moran GW; Ghosh S
    Immunotherapy; 2016 May; 8(5):495-502. PubMed ID: 27140405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.